Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGFBP3 | P17936 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | TTR | P02766 | 2/20 | 0.46 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.42 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21628798 | 0.92 | LMNA (0.49) | IGFBP3LMNAMAPK1HTTRAB9A | |
| SCHEMBL21628455 | 0.91 | LMNA (0.48) | IGFBP3LMNAMAPK1HTTRAB9A | |
| SCHEMBL21628817 | 0.89 | LMNA (0.51) | IGFBP3LMNAMAPK1HTTRAB9A | |
| SCHEMBL21656739 | 0.89 | IGFBP3 (0.59) | IGFBP3LMNAMAPK1HTTRAB9A | |
| SCHEMBL21628807 | 0.88 | PARP10 (0.54) | IGFBP3KDM4EMAPTPARP10 | |
| SCHEMBL21628770 | 0.85 | ALDH1A1 (0.51) | IGFBP3LMNAMAPK1HTTRAB9A | |
| SCHEMBL21628839 | 0.85 | OPRM1 (0.45) | IGFBP3MAPK1KDM4EMAPT | |
| SCHEMBL19357374 | 0.84 | RAB9A (0.56) | IGFBP3LMNAMAPK1HTTRAB9A | |
| SCHEMBL21628649 | 0.84 | HPGD (0.51) | IGFBP3MAPK1HTTKDM4EMAPT | |
| SCHEMBL21628846 | 0.84 | SLC6A2 (0.53) | IGFBP3LMNAMAPK1HTTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600696-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2026-04-14 | — | — | US | disclosed |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-12-21 | — | — | US | disclosed |
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2022-11-03 | — | — | US | disclosed |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2021-04-15 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | IGFBP3 3214/4885LMNA 3327/4885MAPK1 3508/4885 |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | IGFBP3 3214/4885LMNA 3327/4885MAPK1 3508/4885 |
| US-11591289-B2 | Aromatic compounds | AHR, TYR, MUSK | IGFBP3 2998/4885LMNA 3083/4885MAPK1 3401/4885 |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | IGFBP3 3214/4885LMNA 3327/4885MAPK1 3508/4885 |
| US-12600696-B2 | Aromatic compounds | CCR1, CCRL2, AHR | IGFBP3 1912/4885LMNA 832/4885MAPK1 2406/4885 |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | IGFBP3 3214/4885LMNA 3327/4885MAPK1 3508/4885 |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | IGFBP3 3214/4885LMNA 3327/4885MAPK1 3508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.